Max India Limited Board Meeting Scheduled for February 10, 2026 to Consider Q3FY26 Unaudited Financial Results

1 min read     Updated on 03 Feb 2026, 05:08 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Max India Limited has scheduled a Board of Directors meeting for February 10, 2026, to consider unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement, made on February 3, 2026, complies with SEBI regulations. Trading window restrictions are in place for designated persons until February 12, 2026, following the company's insider trading policy.

31664313

*this image is generated using AI for illustrative purposes only.

Max india Limited has officially announced a Board of Directors meeting scheduled for February 10, 2026, to review and consider the company's unaudited financial results for the third quarter of fiscal year 2026. The announcement was made on February 3, 2026, through a formal communication to both BSE Limited and the National Stock Exchange of India Limited.

Meeting Details and Regulatory Compliance

The board meeting has been convened in accordance with Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting represents a continuation of the company's earlier announcement dated December 26, 2025.

Parameter: Details
Meeting Date: February 10, 2026
Purpose: Consider unaudited financial results
Period Covered: Quarter and nine months ended December 31, 2025
Results Type: Both standalone and consolidated
Regulatory Framework: SEBI (LODR) Regulations, 2015

Trading Window Restrictions

In compliance with the company's Policy on Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, Max India Limited has implemented trading restrictions for designated persons. The trading window for dealing in company shares will remain closed for all designated persons, including their immediate relatives.

Restriction Details: Timeline
Trading Window Status: Closed
Applicable To: All designated persons and immediate relatives
Closure Period: Until 48 hours post-results announcement
Expected Reopening: February 12, 2026

Corporate Information

The announcement was signed by Trapti, Company Secretary & Compliance Officer, on February 3, 2026. Max India Limited operates under CIN L74999MH2019PLC320039, with its corporate office located in Gurgaon, Haryana, and registered office in Mumbai, Maharashtra.

Corporate Details: Information
Scrip Code (BSE): 543223
Symbol (NSE): MAXIND
CIN: L74999MH2019PLC320039
Corporate Office: Gurgaon, Haryana
Registered Office: Mumbai, Maharashtra

The company has requested both stock exchanges to take note of this announcement and the associated trading restrictions that will remain in effect until the completion of the regulatory disclosure process.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
+4.73%+5.96%-14.12%-23.35%-30.46%+176.78%

Max India's AGEasy Launches Senior-Specific Gut Care Range

2 min read     Updated on 15 Dec 2025, 11:35 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Antara Assisted Care Services, a subsidiary of Max India Limited, has introduced AGEasy's Gut Care Range, developed in partnership with Wellbeing Nutrition. The product line addresses digestive health issues specific to India's aging population. The range includes four formulations: GutBalance, ConstiCalm, BloatCalm, and AcidityCalm, all designed to meet seniors' unique physiological needs. The products are FSSAI-certified, plant-based, and free from common allergens. This launch aims to fill a gap in the Indian healthcare market, where 4 in 10 urban seniors experience persistent digestive issues.

27324315

*this image is generated using AI for illustrative purposes only.

Max India Limited's wholly-owned subsidiary Antara Assisted Care Services has announced a significant expansion in the senior care market with the launch of AGEasy's specialized Gut Care Range. Developed in partnership with Wellbeing Nutrition, this new product portfolio addresses the overlooked digestive challenges faced by India's aging population.

Market Need and Research Insights

The launch addresses a critical gap in the Indian healthcare market, where gut health products are typically designed for the general population. Recent studies reveal concerning statistics about senior digestive health:

Health Parameter Statistics
Urban seniors with digestive discomfort 4 in 10 experience persistent issues
Seniors seeking active treatment Nearly 50.00%
Common conditions Constipation, IBS, and IBD

Seniors face unique physiological challenges that make their digestive systems more sensitive, including slower metabolism, altered gut microbiome, higher medication load, and reduced digestive enzyme activity. These factors increase both the frequency and severity of digestive discomfort among the aging population.

Product Portfolio and Specifications

The AGEasy Gut Care Range features four targeted formulations designed specifically for senior physiology:

Product Purpose
GutBalance Daily digestive support for overall gut wellness
ConstiCalm Support for regular bowel movement
BloatCalm Relief from heaviness, gas and discomfort
AcidityCalm Help with acidity and related digestive distress

All products in the range are FSSAI-certified and utilize clinically validated, globally sourced ingredients. The formulations are plant-based, gluten-free, lactose-free, GMO-free, and contain no added sugar. The products are specifically designed for optimal absorption and ease of use, addressing common senior concerns like pill fatigue and dysphagia.

Leadership Perspectives

Ishaan Khanna, CEO of Antara Assisted Care Services, emphasized the foundational importance of gut health for seniors. He highlighted that scientific literature demonstrates gut health's influence on immunity, inflammation, metabolic parameters, and cognitive function. The collaboration combines AGEasy's understanding of senior needs with Wellbeing Nutrition's scientific rigor to create sustained, reliable support for digestive concerns.

Avnish Chhabria, Founder CEO of Wellbeing Nutrition, reinforced the partnership's commitment to making clean, research-driven nutrition accessible across all life stages. He noted that the collaboration addresses seniors' specific challenges including reduced nutrient absorption and ease of use requirements.

Company Background and Market Position

Antara Senior Care, launched in 2013, operates as the senior-care business of Max India Limited, part of the ₹7.00 billion Max Group. The integrated ecosystem operates through two main business lines: Residences for Seniors and Assisted Care Services. AGEasy, launched in 2023, has already touched over 5.00 lakh lives and offers products across lung care, joint health, fall prevention, diabetes management, and now gut health.

Wellbeing Nutrition, founded in 2019, raised ₹10.00 million in a Series B round led by Hindustan Unilever Ltd. and Fireside Ventures. The company specializes in FDA-approved, science-backed nutraceuticals across various health categories including sleep, gut health, beauty, stress, immunity, and vitamins.

Strategic Impact

This launch represents AGEasy's continued mission of making aging easier through thoughtfully curated products addressing chronic health needs. The partnership creates India's first dedicated gut care range for the aging population, positioning both companies at the forefront of the specialized senior healthcare market. The collaboration demonstrates the growing recognition of age-specific healthcare needs and the market opportunity in serving India's expanding senior demographic.

The new AGEasy Gut Care Range features four targeted formulations addressing digestive concerns for seniors with science-backed ingredients, further solidifying Max India's commitment to providing specialized care solutions for the aging population.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
+4.73%+5.96%-14.12%-23.35%-30.46%+176.78%

More News on Max India

1 Year Returns:-30.46%